STEPHEN P SQUINTO Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for STEPHEN P SQUINTO.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of STEPHEN P SQUINTO. STEPHEN P SQUINTO is a EVP & Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP & Head of Research & Devel in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP, Chief Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP, Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP, Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP, Research & Development in ALEXION PHARMACEUTICALS INC ($ALXN) and a EVP, Research and Development in ALEXION PHARMACEUTICALS INC ($ALXN) and a Exec VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and a Exec VP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and a Exec. VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and an Executive VP in ALEXION PHARMACEUTICALS INC ($ALXN) and an Executive VP& Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and an Executive VP/Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and a Director in Chemomab Therapeutics Ltd. ($ANCN) and a Director in Audentes Therapeutics, Inc. ($BOLD) and a Director in SpringWorks Therapeutics, Inc. ($SWTX) and a Head of Research and Dev in Passage BIO, Inc. ($PASG).

Address: C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE 06410 CT

Companies in which STEPHEN P SQUINTO is an Insider

ALEXION PHARMACEUTICALS, INC.

Trading Symbol: ALXN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN P SQUINTO: EVP, Chief Global Ops. Officer, EVP, Global Ops. Officer, EVP, Head of R&D, EVP, Research & Development, EVP, Research and Development, EVP & Head of R&D, EVP & Head of Research & Devel, EVP & Head of Research, EVP, Head of Research, Executive VP& Head of
Holdings: 106,508 shares
Current Value: $13,603,202
Latest Transaction: Oct 28 2014
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Audentes Therapeutics, Inc.

Trading Symbol: BOLD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN P SQUINTO: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 10 2017
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Chemomab Therapeutics Ltd.

Trading Symbol: ANCN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN P SQUINTO: Director
Holdings: 0 shares
Latest Transaction: Apr 21 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Passage BIO, Inc.

Trading Symbol: PASG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN P SQUINTO: Head of Research and Dev
Holdings: 0 shares
Latest Transaction: Mar 02 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SpringWorks Therapeutics, Inc.

Trading Symbol: SWTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN P SQUINTO: Director
Holdings: 144,959 shares
Latest Transaction: Apr 28 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of STEPHEN P SQUINTO

Sentiment: All, ALXN, BOLD, ANCN, PASG, SWTX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 28 2021SWTXSpringWorks Therap ...SQUINTO STEPHEN PDirectorSellS76.2019,2311,465,437125,728145 K to 125.7 K (-13.27 %)
Apr 28 2021SWTXSpringWorks Therap ...SQUINTO STEPHEN PDirectorSellS75.0520115,085144,959145.2 K to 145 K (-0.14 %)
Apr 21 2021ANCNChemomab Therapeut ...SQUINTO STEPHEN PDirectorOption ExerciseA27.2623,768647,91623,768
Apr 19 2021SWTXSpringWorks Therap ...SQUINTO STEPHEN PDirectorSellS75.011,05779,291145,160146.2 K to 145.2 K (-0.72 %)
Apr 19 2021SWTXSpringWorks Therap ...SQUINTO STEPHEN PDirectorSellS75.0851138,365146,217146.7 K to 146.2 K (-0.35 %)
May 22 2020SWTXSpringWorks Therap ...SQUINTO STEPHEN PDirectorOption ExerciseA38.037,464283,8567,464
Mar 13 2020SWTXSpringWorks Therap ...SQUINTO STEPHEN PDirectorOption ExerciseA28.7620,000575,20020,000

View all STEPHEN P SQUINTO insider transactions.